BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magill SS, O'Leary E, Ray SM, Kainer MA, Evans C, Bamberg WM, Johnston H, Janelle SJ, Oyewumi T, Lynfield R, Rainbow J, Warnke L, Nadle J, Thompson DL, Sharmin S, Pierce R, Zhang AY, Ocampo V, Maloney M, Greissman S, Wilson LE, Dumyati G, Edwards JR; Emerging Infections Program Hospital Prevalence Survey Team. Antimicrobial Use in US Hospitals: Comparison of Results From Emerging Infections Program Prevalence Surveys, 2015 and 2011. Clin Infect Dis 2021;72:1784-92. [PMID: 32519751 DOI: 10.1093/cid/ciaa373] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Pfaller M, Shortridge D, Chen W, Sader H, Castanheira M. Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016–2018). IDR 2022;Volume 15:6739-6753. [DOI: 10.2147/idr.s387097] [Reference Citation Analysis]
2 Puzniak LA, Bauer KA, Yu KC, Watts JA, Ai C, Gupta V. A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves.. [DOI: 10.21203/rs.3.rs-1781463/v1] [Reference Citation Analysis]
3 Pais GM, Chang J, Barreto EF, Stitt G, Downes KJ, Alshaer MH, Lesnicki E, Panchal V, Bruzzone M, Bumanglag AV, Burke SN, Scheetz MH. Clinical Pharmacokinetics and Pharmacodynamics of Cefepime. Clin Pharmacokinet 2022. [PMID: 35764774 DOI: 10.1007/s40262-022-01137-y] [Reference Citation Analysis]
4 Nunes PHC, Moreira JPDL, Thompson ADF, Machado TLDS, Cerbino-neto J, Bozza FA. Antibiotic Consumption and Deviation of Prescribed Daily Dose From the Defined Daily Dose in Critical Care Patients: A Point-Prevalence Study. Front Pharmacol 2022;13:913568. [DOI: 10.3389/fphar.2022.913568] [Reference Citation Analysis]
5 Kahn DJ, Perkins BS, Barrette CE, Godin R. Reducing Antibiotic Use in a Level III and Two Level II Neonatal Intensive Care Units Targeting Prescribing Practices for Both Early and Late-onset Sepsis: A Quality Improvement Project. Pediatric Quality & Safety 2022;7:e555. [DOI: 10.1097/pq9.0000000000000555] [Reference Citation Analysis]
6 Shi Z, Hon J, Cheng C, Chiang H, Huang H. Applying Machine Learning Techniques to the Audit of Antimicrobial Prophylaxis. Applied Sciences 2022;12:2586. [DOI: 10.3390/app12052586] [Reference Citation Analysis]
7 Spottiswoode N, Bloomstein JD, Caldera S, Sessolo A, Mccauley K, Byanyima P, Zawedde J, Kalantar K, Kaswabuli S, Rutishauser RL, Lieng MK, Davis JL, Moore J, Jan A, Iwai S, Shenoy M, Sanyu I, Derisi JL, Lynch SV, Worodria W, Huang L, Langelier CR. Pneumonia surveillance with culture-independent metatranscriptomics in HIV-positive adults in Uganda: a cross-sectional study. The Lancet Microbe 2022. [DOI: 10.1016/s2666-5247(21)00357-8] [Reference Citation Analysis]
8 O'Leary EN, Edwards JR, Srinivasan A, Neuhauser MM, Soe MM, Webb AK, Edwards EM, Horbar JD, Soll RF, Roberts J, Hicks LA, Wu H, Zayack D, Braun D, Cali S, Edwards WH, Flannery DD, Fleming-Dutra KE, Guzman-Cottrill JA, Kuzniewicz M, Lee GM, Newland J, Olson J, Puopolo KM, Rogers SP, Schulman J, Septimus E, Pollock DA. National Healthcare Safety Network 2018 Baseline Neonatal Standardized Antimicrobial Administration Ratios. Hosp Pediatr 2022:e2021006253. [PMID: 35075483 DOI: 10.1542/hpeds.2021-006253] [Reference Citation Analysis]
9 Boton NH, Patel PK, Kendall RE, Hershey C, Jarzebowski M. Errors in perioperative antimicrobial use for hospitalized surgical patients. ASHE 2022;2:e162. [DOI: 10.1017/ash.2022.255] [Reference Citation Analysis]
10 Levy Hara G, Rojas-Cortés R, Molina León HF, Dreser Mansilla A, Alfonso Orta I, Rizo-Amezquita JN, Santos Herrera RG, Mendoza de Ayala S, Arce Villalobos M, Mantilla Ponte H, Davila E, Aguilar G, Porrás A, Ramón-Pardo P, Castro JL; Latin American Point Prevalent Survey Study Group . Point prevalence survey of antibiotic use in hospitals in Latin American countries. J Antimicrob Chemother 2021:dkab459. [PMID: 34957520 DOI: 10.1093/jac/dkab459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Klompas M, Baker DL. Finding the balance between overtreatment versus undertreatment for hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2021;:1-3. [PMID: 34847978 DOI: 10.1017/ice.2021.474] [Reference Citation Analysis]
12 Sridhar S, Kanne JP, Henry TS, Revels JW, Gotway MB, Ketai LH. Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem. Radiographics 2021;:210146. [PMID: 34826256 DOI: 10.1148/rg.210146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hsieh ES, Bollig ER, Beaudoin AL, Morrow A, Granick JL. Serial point-prevalence surveys to estimate antibiotic use in a small animal veterinary teaching hospital, November 2018 to October 2019. J Vet Intern Med 2021. [PMID: 34773289 DOI: 10.1111/jvim.16314] [Reference Citation Analysis]
14 Papan C, Argentiero A, Porwoll M, Hakim U, Farinelli E, Testa I, Pasticci MB, Mezzetti D, Perruccio K, Etshtein L, Mastboim N, Moscoviz E, Ber TI, Cohen A, Simon E, Boico O, Shani L, Gottlieb TM, Navon R, Barash E, Oved K, Eden E, Simon A, Liese JG, Knuf M, Stein M, Yacobov R, Bamberger E, Schneider S, Esposito S, Tenenbaum T. A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study. Clin Microbiol Infect 2021:S1198-743X(21)00621-2. [PMID: 34768022 DOI: 10.1016/j.cmi.2021.10.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
15 Chang J, Pais G, Valdez K, Marianski S, Barreto EF, Scheetz MH. Glomerular function and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model.. [DOI: 10.1101/2021.11.08.467852] [Reference Citation Analysis]
16 German GJ, Frenette C, Caissy J, Grant J, Lefebvre M, Mertz D, Lutes S, Mcgeer A, Roberts J, Afra K, Valiquette L, Émond Y, Carrier M, Lauzon-laurin A, Nguyen TT, Al-bachari H, Kosar J, Peermohamed S, Science M, Landry D, Maclaggan T, Daley P, Mcdonald G, Ang A, Chang S, Lin Y, Tong B, Malfair S, Leung V, Katz K, Pauwels I, Goossens H, Versporten A, Conly J, Thirion DJ. The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey. cmajo 2021;9:E1242-E1251. [DOI: 10.9778/cmajo.20200274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Khamis AS, Chai LC. Chemical and Antimicrobial Analyses of Juniperus chinensis and Juniperus seravschanica Essential Oils and Comparison with Their Methanolic Crude Extracts. Int J Anal Chem 2021;2021:9937522. [PMID: 34497647 DOI: 10.1155/2021/9937522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Eubank TA, Zaidan N, Alnezary FS, Moc C, Olson K, Zaki A, McDaneld PM, Gonzales-Luna AJ; Houston Infectious Diseases Network. Significant Publications on Infectious Diseases Pharmacotherapy in 2020. J Pharm Pract 2021;:8971900211040438. [PMID: 34449277 DOI: 10.1177/08971900211040438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Elliott BP, Tang MM, Madden JA, Markert RJ, Burdette SD, Pleiman CM, Speelmon EC. A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime. Intern Emerg Med 2021. [PMID: 34089468 DOI: 10.1007/s11739-021-02772-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Magill SS, O'Leary E, Ray SM, Kainer MA, Evans C, Bamberg WM, Johnston H, Janelle SJ, Oyewumi T, Lynfield R, Rainbow J, Warnke L, Nadle J, Thompson DL, Sharmin S, Pierce R, Zhang AY, Ocampo V, Maloney M, Greissman S, Wilson LE, Dumyati G, Edwards JR, Chea N, Neuhauser MM; Emerging Infections Program Hospital Prevalence Survey Team. Assessment of the Appropriateness of Antimicrobial Use in US Hospitals. JAMA Netw Open 2021;4:e212007. [PMID: 33734417 DOI: 10.1001/jamanetworkopen.2021.2007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]